GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Total Stockholders Equity

ViaDerma (ViaDerma) Total Stockholders Equity : $35.10 Mil (As of Jun. 2012)


View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Total Stockholders Equity?

ViaDerma's Total Stockholders Equity for the quarter that ended in Jun. 2012 was $35.10 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ViaDerma's Book Value per Share for the quarter that ended in Jun. 2012 was $255.59. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ViaDerma's Debt-to-Equity for the quarter that ended in Jun. 2012 was 0.21.


ViaDerma Total Stockholders Equity Historical Data

The historical data trend for ViaDerma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Total Stockholders Equity Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Total Stockholders Equity
0.01 17.19 23.45 29.21 33.56

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.86 32.70 33.56 34.12 35.10

ViaDerma  (OTCPK:VDRM) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ViaDerma's Book Value per Share for the quarter that ended in Jun. 2012 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ViaDerma's Debt-to-Equity for the quarter that ended in Jun. 2012 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ViaDerma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ViaDerma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


ViaDerma (ViaDerma) Business Description

Traded in Other Exchanges
N/A
Address
4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.

ViaDerma (ViaDerma) Headlines

From GuruFocus

ViaDerma, Inc. Provides a Corporate Update

By Marketwired Marketwired 06-23-2020

ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021

By Marketwired Marketwired 01-13-2021

ViaDerma, Inc. Provides a Corporate Update

By Marketwired Marketwired 01-16-2020

ViaDerma Provides an Update to Shareholders via a Letter from the CEO

By GlobeNewswire GlobeNewswire 07-12-2018

ViaDerma, Inc. Provides a Corporate Update

By GlobeNewswire GlobeNewswire 01-16-2020

ViaDerma Provides an Update on Current & Future Business Activities

By sperokesalga sperokesalga 03-02-2023

ViaDerma, Inc. Provides an Update on its Current Marketing Efforts

By Marketwired Marketwired 08-27-2020